MA24794A1 - D-methadone, un analgesique nonopioique - Google Patents

D-methadone, un analgesique nonopioique

Info

Publication number
MA24794A1
MA24794A1 MA24934A MA24934A MA24794A1 MA 24794 A1 MA24794 A1 MA 24794A1 MA 24934 A MA24934 A MA 24934A MA 24934 A MA24934 A MA 24934A MA 24794 A1 MA24794 A1 MA 24794A1
Authority
MA
Morocco
Prior art keywords
alpha
subject
methadone
nonopioic
analgesic
Prior art date
Application number
MA24934A
Other languages
English (en)
Original Assignee
Cornell Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Res Foundation Inc filed Critical Cornell Res Foundation Inc
Publication of MA24794A1 publication Critical patent/MA24794A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MA24934A 1997-01-22 1998-01-22 D-methadone, un analgesique nonopioique MA24794A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US3530897P 1997-01-22 1997-01-22

Publications (1)

Publication Number Publication Date
MA24794A1 true MA24794A1 (fr) 1999-12-31

Family

ID=21881853

Family Applications (1)

Application Number Title Priority Date Filing Date
MA24934A MA24794A1 (fr) 1997-01-22 1998-01-22 D-methadone, un analgesique nonopioique

Country Status (12)

Country Link
US (1) US6008258A (fr)
EP (1) EP1003494B1 (fr)
JP (2) JP4514241B2 (fr)
AT (1) ATE357226T1 (fr)
AU (1) AU6244898A (fr)
CA (1) CA2278422C (fr)
DE (1) DE69837387T2 (fr)
DK (1) DK1003494T3 (fr)
ES (1) ES2283049T3 (fr)
MA (1) MA24794A1 (fr)
PT (1) PT1003494E (fr)
WO (1) WO1998031358A1 (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070197651A1 (en) * 1998-03-09 2007-08-23 Tufts University Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors
US20060167114A1 (en) * 1998-03-09 2006-07-27 Louis Shuster Treatment of stereotypic, self-injurious and compulsive behaviors in man and animals using antagonists of NMDA receptors
EP1061924A1 (fr) * 1998-03-09 2000-12-27 Trustees Of Tufts College Traitement des comportements compulsifs chez l'homme et l'animal
BR9912827A (pt) 1998-07-16 2001-05-02 Sloan Kettering Inst Cancer Composições tópicas compreendendo um analgésico opióide e um antagonista de nmda
US6897242B1 (en) * 1999-02-24 2005-05-24 Judson J. Somerville Non-racemic mixtures of d- and l- methadone and method of treating pain
AU2001251374A1 (en) * 2000-04-07 2001-10-23 Ultramed International, Inc. Maintaining abstinence after detoxification from opiate addiction
IL152473A0 (en) 2000-04-28 2003-05-29 Sloan Kettering Inst Cancer Topical anesthetic/opioid formulations and uses thereof
US7820688B2 (en) 2001-04-27 2010-10-26 Memorial Sloan-Kettering Cancer Center Topical anesthetic/opioid formulations and uses thereof
EP1471909A4 (fr) * 2002-01-16 2007-07-25 Endo Pharmaceuticals Inc Composition pharmaceutique et methode de traitement de troubles du systeme nerveux central
EP1476155A4 (fr) * 2002-01-23 2009-10-28 Univ California Procedes et compositions destines a reduire le developpement de tolerance au medicament et/ou de dependance physique
CA2486095A1 (fr) * 2002-05-13 2004-05-21 Endo Pharmaceuticals Inc. Forme posologique opioide empechant une utilisation abusive
WO2004022002A2 (fr) * 2002-09-09 2004-03-18 Endo Pharmaceuticals Inc. Composition analgesique combinee a liberation immediate et prolongee
US20040180915A1 (en) * 2003-03-14 2004-09-16 Xanodyne Pharmacal, Inc. Methadone-containing compositions for parenteral administration and method of use thereof
US20040202717A1 (en) 2003-04-08 2004-10-14 Mehta Atul M. Abuse-resistant oral dosage forms and method of use thereof
US20100010096A1 (en) * 2006-10-27 2010-01-14 John Charin Somberg Methadone chiral isolate as an improved pharmaceutical
US20100048605A1 (en) * 2006-12-11 2010-02-25 University Of Kentucky Research Foundation Synergistic effects of combinations of nornicotine and opioids for the treatment of pain
US9468611B2 (en) * 2012-09-27 2016-10-18 Relmada Therapeutics, Inc. d-Methadone for the treatment of psychiatric symptoms
AU2018215056A1 (en) 2017-01-31 2019-08-08 Charles E. Inturrisi D-methadone and its derivatives for use in the treatment of disorders of the nervous system
WO2018183320A1 (fr) * 2017-03-31 2018-10-04 Depco, Inc. Mastic thérapeutique à analgésiques et/ou révulsifs
EP3917619A4 (fr) * 2019-01-30 2022-10-26 University of Padova Opioïdes à modification structurale pour la prévention et le traitement de maladies et de pathologies

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3895056A (en) * 1972-12-26 1975-07-15 Lilly Co Eli Alpha-d1-4-acetoxy-1-methyl-3,3-diphenylhexylamine and salts
US5321012A (en) * 1993-01-28 1994-06-14 Virginia Commonwealth University Medical College Inhibiting the development of tolerance to and/or dependence on a narcotic addictive substance
CA2115792C (fr) * 1993-03-05 2005-11-01 David J. Mayer Methode de traitement de la douleur
US5352683A (en) * 1993-03-05 1994-10-04 Virginia Commonwealth University Medical College Of Virginia Method for the treatment of chronic pain

Also Published As

Publication number Publication date
US6008258A (en) 1999-12-28
CA2278422A1 (fr) 1998-07-23
JP4514241B2 (ja) 2010-07-28
EP1003494A1 (fr) 2000-05-31
JP2010013477A (ja) 2010-01-21
DK1003494T3 (da) 2007-07-16
AU6244898A (en) 1998-08-07
DE69837387D1 (de) 2007-05-03
ES2283049T3 (es) 2007-10-16
PT1003494E (pt) 2007-06-06
DE69837387T2 (de) 2007-12-13
ATE357226T1 (de) 2007-04-15
EP1003494B1 (fr) 2007-03-21
EP1003494A4 (fr) 2002-10-16
JP2001508797A (ja) 2001-07-03
WO1998031358A1 (fr) 1998-07-23
CA2278422C (fr) 2007-11-13

Similar Documents

Publication Publication Date Title
MA24794A1 (fr) D-methadone, un analgesique nonopioique
IL128003A (en) MULTISPECIFIC BINDING MOLECULES COMPRISING A BINDING DETERMINANT WHICH BINDS AN FCalpha RECEPTOR
FR12C0001I2 (fr) Anticorps se liant de maniere immunospecifique a un stimulateur de lymphocyte b
ATE301994T1 (de) Verfahren zur erleichterung von schmerzen durch eine kombination von tramadol und einen nmda- antagonist
FI965203A7 (fi) Morfiinia, polypyrrolidonia ja polyalkyleenioksidia sisältävä koostumus
CA2146973A1 (fr) Utilisations d'un fragment du recepteur du tgf-.beta. a des fins therapeutiques
DE69733081D1 (de) Antikonvulsive mitteln enthaltende zubereitung zur behandlung von neuropathischen schmerzen
BR9910180A (pt) Composição farmacêutica, processos para o tratamento de uma condição associada com a transmissão reduzida de nicotina, para identificação de um modulador positivo de um agonista receptor nicotìnico e para identificação de um composto, composto, e, uso de um modulador positivo de um agonista receptor nicotìnico
IT8822374A0 (it) Procedimento per distribuire, su richiesta, copie di documenti immagazzinati in forma leggibile da macchina.
AU1718400A (en) Method for treating pain
TR200000755T2 (tr) Karşıt olma-karşı gelme bozukluğunun tedavisi.
DK1063995T3 (da) Kombination til behandling af alkoholafhængighed indeholdende en opiod-antagonist og en NMDA-receptorkompleks-modulator
BR0110208A (pt) Composições e terapias para distúrbios associados com hiperlipidemia
SE9603725D0 (sv) New teatment
DE59609508D1 (de) Konjugat enthaltend dtpa und albumin zur individuellen dosierung von arzneimitteln
DK0946157T3 (da) Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte
DK0846173T3 (da) Anvendelse af et anti-interleukin-9-antistof til fremstilling af et lægemiddel til behandling af astma
EA199800866A1 (ru) Способ снятия боли
MY133169A (en) Substituted heterocyclic benzocycloalkenes and the use thereof as substances having an analgesic effect
WO1998020835A3 (fr) Methode pour traiter l'hyperlipidemie chez l'homme
CA2299400A1 (fr) Methode de traitement de dyskinesies liees a une maladie ou provoquees par l'absorption de medicaments
EA199800535A1 (ru) Способ лечения боли
WO2000051632A3 (fr) Agoniste du cuivre qui se lie au site de fixation de cuivre de l'app et/ou exerce une action d'inhibition sur la liberation du peptide beta-amyloide
AU4937499A (en) Use of succinic acid or salts thereof and method of treating insulin resistance
ES2173879T3 (es) Procedimiento para la preparacion de conjugados a base de un participe especifico en la fijacion y de una proteina que contiene hidratos de carbono